ARAY — ACCURAY INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1138723 ·
Last close
$2.44
Market Cap
$7.33M
52W High
$45.20
52W Low
$2.39
ADV30
73,021
Next earnings
2027-02-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 100,919,000 | 35,077,000 | 6,271,000 | -1,941,000 | 443,676,000 | 40,623,000 | 401,977,000 |
| Mar 2026 | 104,845,000 | 25,294,000 | -2,548,000 | -11,805,000 | 447,602,000 | 38,067,000 | 405,895,000 |
| Dec 2025 | 102,241,000 | 24,072,000 | -5,491,000 | -13,770,000 | 448,009,000 | 41,295,000 | 394,589,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,981,000
Investing CF
$-12,279,000
Financing CF
$6,977,000
CapEx
$-12,279,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.15
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-568,466,000
Inventory
$147,075,000
Receivables
$89,248,000
ST Investments
—
EBIT TTM
$-14,343,000
Pretax Income TTM
$-47,248,000
Interest Exp TTM
$32,905,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$401,947,008
EBITDA
$-3,528,000
Free Cash Flow
$10,565,625
Enterprise Value
$161,059,408
Total Cash
$40,623,000
Total Debt
$183,874,000
Shares Out
3,005,000
Trailing EPS
$-5.60
Book Value
$0.35
ROE
-80.1%
ROA
-1.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 401,947,000 | -10,270,000 | -49,194,000 | 443,676,000 | 401,977,000 | 41,699,000 | -6,981,000 |
| Jun 2025 | 458,505,000 | 7,839,000 | -1,591,000 | 470,239,000 | 389,070,000 | 81,169,000 | 2,860,000 |
| Jun 2024 | 446,551,000 | 504,000 | -15,545,000 | 468,627,000 | 423,543,000 | 45,084,000 | -11,904,000 |
| Jun 2023 | 447,605,000 | 2,382,000 | -9,280,000 | 479,214,000 | 425,555,000 | 53,659,000 | 15,539,000 |
TTM Snapshot
Revenues TTM
$401,947,000
NetIncome TTM
$-49,194,000
OpCashFlow TTM
—
Assets (Latest)
$447,602,000
Forward EPS
$-0.24
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.00 · spot: $2.50 · call volume: 23 · put volume: 15
Expected Move to 2026-12-18:
±$1.90
(76.00%) —
implied range
$0.60 –
$4.40
· ATM straddle on $2.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ADMT | ADM TRONICS UNLIMITED, INC. | $7.98M | $0.12 | — |
| GTHP | GUIDED THERAPEUTICS INC | $8.30M | $0.09 | — |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $6.43M | $0.71 | — |
| STME | Stimcell Energetics Inc. | $6.34M | $0.30 | — |
| CLGN | CollPlant Biotechnologies Ltd | $6.30M | $3.33 | — |
News headlines (Yahoo Finance, 1h cache)
Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
2026-11-13 22:10 · Yahoo
Accuray (ARAY) Q1 2027 Earnings Call Transcript
2026-11-05 22:01 · Yahoo
Accuray Incorporated Q1 2027 Earnings Call Summary
2026-11-05 13:30 · Yahoo
Accuray Inc (ARAY) (Q1 2027) Earnings Call Highlights: Service Strength and Cost Cuts Offset by ...
2026-11-05 13:09 · Yahoo
Accuray: Fiscal Q1 Earnings Snapshot
2026-11-04 21:24 · Yahoo
Accuray Announces 1-for-40 Reverse Stock Split
2026-11-04 21:20 · Yahoo
Accuray Reports Fiscal 2027 First Quarter Financial Results
2026-11-04 21:05 · Yahoo
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
2026-10-30 20:10 · Yahoo
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
2026-10-21 20:05 · Yahoo
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
2026-10-06 20:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.